Conference Coverage

Management of IBD in older patients

Publish date: March 21, 2018
By
Bruce Jancin

 

EXPERT ANALYSIS FROM GUILD 2018

MAUI, HAWAII – Misconceptions abound regarding inflammatory bowel disease (IBD) in the elderly, Uma Mahadevan, MD, said at the Gastroenterology, IBD, Liver Disease meeting.

Dr. Uma Mahadevan, director of center for Chron's and Colitis, University of California, San Francisco Bruce Jancin/Frontline Medical News

Dr. Uma Mahadevan

Among these commonly held inaccurate beliefs are that elderly-onset IBD is not all that common, that it’s typically milder than in younger patients, and that older patients are unlikely to tolerate immunosuppressants, according to Dr. Mahadevan, course chairman and professor of medicine and director of the Center for Colitis and Crohn’s Disease at the University of California, San Francisco.

In addition to dispelling these notions, she outlined her favored treatment strategies in older IBD patients.

Pages

Recommended Reading

Xeljanz: FDA panel recommends ulcerative colitis indication
MDedge Internal Medicine
Nonendoscopic nonmalignant polyp surgery increasing despite greater risk
MDedge Internal Medicine
FDA issues warning to all duodenoscope manufacturers
MDedge Internal Medicine
New study establishes IBD severity index
MDedge Internal Medicine
Gut bacteria could drive autoimmune response in genetically predisposed
MDedge Internal Medicine
Colorectal cancer risk stratification enhanced by combining family history and genetic risk scores
MDedge Internal Medicine
MDedge Daily News: Why the barber’s chair can help hypertension
MDedge Internal Medicine
Bile spillage during lap cholecystectomy comes with a price
MDedge Internal Medicine
Do not miss cannabis use in gastroparesis patients
MDedge Internal Medicine
Abdominal pain with high transaminases
MDedge Internal Medicine